Results 31 to 40 of about 47,941 (305)

A comparative study between isosorbide mononitrate (IMN) versus misoprostol prior to hysteroscopy

open access: yesMiddle East Fertility Society Journal, 2010
Objective: To compare the efficacy of a nitric oxide donor (isosorbide mononitrate) and a prostaglandin E1 analogue (misoprostol) for cervical priming before hysteroscopy. Design: Comparative clinical trial.
Waleed El-Khayat   +2 more
doaj   +1 more source

Attenuation of ischemic liver injury by prostaglandin E1 analogue, misoprostol, and prostaglandin I2 analogue, OP-41483 [PDF]

open access: yes, 1998
Background: Prostaglandin has been reported to have protective effects against liver injury. Use of this agent in clinical settings, however, is limited because of drugrelated side effects.
Ishizaki, N   +8 more
core   +1 more source

A double-blind randomized controlled trial of two different doses of misoprostol for cervical priming prior to office hysteroscopy

open access: yesMiddle East Fertility Society Journal, 2015
Objective: To evaluate and compare the effectiveness of 200 μg vaginal misoprostol vs. 400 μg vaginal misoprostol administrated 3 h prior to office hysteroscopy, in cervical priming. Design: Randomized controlled trial.
Waleed El-Khayat   +3 more
doaj   +1 more source

Efficacy of Misoprostol Alone for First-Trimester Medical Abortion: A Systematic Review.

open access: yesObstetrics and Gynecology, 2019
OBJECTIVE To summarize available data on the effectiveness and safety of single-agent misoprostol for medical abortion in the first trimester. DATA SOURCES We searched MEDLINE, CABI, Cochrane, EMBASE, LILACS, the Web of Science, and ClinicalTrials.gov ...
E. Raymond, Margo S. Harrison, M. Weaver
semanticscholar   +1 more source

Efficacy of misoprostol for the treatment of postpartum hemorrhage: current knowledge and implications for health care planning. [PDF]

open access: yes, 2016
BackgroundA myriad of interventions exist to treat postpartum hemorrhage (PPH), ranging from uterotonics and hemostatics to surgical and aortic compression devices. Nonetheless, PPH remains the leading cause of maternal mortality worldwide.
Prata, Ndola, Weidert, Karen
core   +1 more source

Medication Abortion: A Sample Protocol for Increasing Access During a Pandemic and Beyond [PDF]

open access: yes, 2021
No ...
Atrio, Jessica   +10 more
core  

Misoprostol Induced Convulsion- A Rare Side Effect of Misoprostol

open access: yesJOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2017
Misoprostol, a synthetic prostaglandin E1 has wider application in obstetrics gynaecology. It has been recommended in the prophylaxis and treatment of Post Partum Haemorrhage (PPH) by Federation of Obstetrics and Gynaecology (FIGO), World Health Organisation (WHO) and American College of Obstetrics and Gynaecology (ACOG).
Santa Singh Ahanthem   +3 more
openaire   +4 more sources

Prevention of postpartum hemorrhage in low-resource settings: current perspectives. [PDF]

open access: yes, 2013
BackgroundPostpartum hemorrhage (PPH) is the leading cause of maternal death in low-income countries and is the primary cause of approximately one-quarter of global maternal deaths.
Bell, Suzanne   +2 more
core   +1 more source

Safety and efficacy of double-balloon catheter for cervical ripening: a Bayesian network meta-analysis of randomized controlled trials

open access: yesBMC Pregnancy and Childbirth, 2022
Background Various methods are used for cervical ripening during the induction of labor. Mechanical and pharmacological methods are commonly used for cervical ripening.
Ge Zhao, Guang Song, Jing Liu
doaj   +1 more source

Comprehensive abortion care: evidence of improvements in hospital-level indicators in Tigray, Ethiopia. [PDF]

open access: yes, 2013
ObjectiveApproximately 18% of maternal deaths in East Africa is attributable to unsafe abortion. Availability of comprehensive abortion care (CAC) services at all levels of the healthcare system, including medical abortion, has the potential to increase ...
Bell, Suzanne   +2 more
core   +2 more sources

Home - About - Disclaimer - Privacy